RIBOFLAVIN 5'-PHOSPHATE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C17H21N4O9P
Molecular Weight	456.3438
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C3=NC(=O)NC(=O)C3=N2

InChI

InChIKey=FVTCRASFADXXNN-SCRDCRAPSA-N

InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,14-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C17H21N4O9P
Molecular Weight	456.3438
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21163s011lbl.pdf
Curator's Comment: Description was created based on several sources, including http://rupharma.com/cytoflavin/ and https://ods.od.nih.gov/factsheets/Riboflavin-HealthProfessional/

Flavin mononucleotide, or riboflavin-5′-phosphate, is a biomolecule produced from riboflavin by the enzyme riboflavin kinase and functions as prosthetic group of various oxidoreductases including NADH dehydrogenase as well as cofactor in biological blue-light photo receptors. Riboflavin (Vitamin B 2) (as riboflavin 5-phosphate sodium) is an ingredient of the FDA approved composition Infuvite Adult, indicated as a daily multivitamin maintenance supplement for adults and children aged 11 and older receiving parenteral nutrition. Infuvite Adult is also indicated in other situations where administration by the intravenous route is required. Such situations include surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states, which may provoke a “stress” situation with profound alterations in the body’s metabolic demands and consequent tissue depletion of nutrients. Flavin mononucleotide is also a component of Cytoflavin, used for the treatment of consequences of cerebral infarction, for the treatment of atherosclerosis, encephalopathy, neurasthenia. Cytoflavin is marketed in Russian Federation.

CNS Activity

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Thymidylate synthase-dihydrofolate reductase, Cryptosporidium hominis 3 Target ID: Thymidylate synthase-dihydrofolate reductase, Cryptosporidium hominis Sources: http://www.ncbi.nlm.nih.gov/pubmed/19059777	Inhibitor 8504		55.0 µM [IC50]
NADH oxidation 3 Target ID: GO:0006116 Sources: http://www.ncbi.nlm.nih.gov/pubmed/26721206	Oxidative Enzyme 3

Conditions

Condition	Modality	Highest Phase	Product
Vitamin deficiency 17 Sources: https://www.drugs.com/pro/infuvite-adult.html	Primary	Approved 8583	Infuvite Adult Approved Use Infuvite Adult is indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition Launch Date 2003
Cerebral infarction 14 Sources: http://rupharma.com/cytoflavin/	Primary	Approved 8583	Cytoflavin Approved Use Indicated for the treatment of consequences of cerebral infarction, for the treatment of atherosclerosis, encephalopathy, neurasthenia
Atherosclerosis 76 Sources: http://rupharma.com/cytoflavin/	Primary	Approved 8583	Cytoflavin Approved Use Indicated for the treatment of consequences of cerebral infarction, for the treatment of atherosclerosis, encephalopathy, neurasthenia

C_max

Value	Dose	Analyte	Population
217.7 nM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED
206.7 nM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED
308.2 nM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED
1209.4 nM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	11.6 mg single, intravenous dose: 11.6 mg route of administration: Intravenous experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

AUC

Value	Dose	Analyte	Population
883.9 nM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED
886.4 nM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED
981.6 nM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FED
532.1 nM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8604671/	11.6 mg single, intravenous dose: 11.6 mg route of administration: Intravenous experiment type: SINGLE co-administered:	RIBOFLAVIN plasma	Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
AA Blocks	AA00IAUN
ABI Chem	AC1LD8D0
AbovChem LLC	HY-B0964
AK Scientific	S188
AK Scientific	X2938
Alfa Chemistry	ACM22251850
AN PharmaTech	AN-23277
Apollo Scientific	BIF4012
BenchChem	B089457	https://www.benchchem.com/product/b089457
BioSynth	W-108348
BLD Pharm	BD264519	http://www.bldpharm.com/products/146-17-8.html
BOC Sciences	130-40-5
Cayman Chemical	18167
Chem-Impex International	259
Chem Scene	CS-0013780	http://www.chemscene.com/146-17-8.html
Chemieliva Pharmaceutical Co., Ltd	PBCM1190390
Combi-Blocks	QB-4442
Compound Cloud	23666409
Compound Cloud	23687712
Compound Cloud	643976
DC Chemicals	DC12237	http://www.dcchemicals.com/product_show-Riboflavine_phosphate.html
eMolecules	108761523
eMolecules	205741990
eMolecules	43339210
eMolecules	6877149
eMolecules	76746566
Lab Seeker	SC-19205
MedChem Express	HY-B0964A	https://www.medchemexpress.com/Riboflavine_phosphate.html
Molnova	M11220
MolPort	MolPort-003-939-021
MolPort	MolPort-004-964-255
MolPort	MolPort-016-582-614
MuseChem	M067043
NovoSeek	643976
Parchem	39312	https://www.parchem.com/chemical-supplier-distributor/Riboflavin-5'-phosphate-039312.aspx
Ryan Scientific	Pizotifen
Selleck Chemicals	S5107
Sigma Aldrich	CDS020791\|ALDRICH
Sigma Aldrich	CDS025203\|ALDRICH
Sigma Aldrich	F2253\|SIGMA
Sigma Aldrich	F6750\|SIGMA
Sigma Aldrich	R0630000\|SIAL
Smolecule	S564790	https://www.smolecule.com/products/s564790
StruChem	SC-19205
Tetrahedron	TS82909
Tetrahedron	TS83394
THE BioTek	bt-364823	https://www.thebiotek.com/product/others/bt-364823
TimTec	SBB057412
TimTec	ST50999669
Toronto Research Chemicals	R415000
W&J PharmaChem	50C579481
ZINC	ZINC000003831425	http://zinc15.docking.org/substances/ZINC000003831425

PubMed

Title	Date	PubMed
Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin.	2011-04	21308351
Identification and functional characterization of rat riboflavin transporter 2.	2009-04	19122205
Efficacy of twice-weekly multiple micronutrient supplementation for improving the hemoglobin and micronutrient status of anemic adolescent schoolgirls in Bangladesh.	2005-10	16210713
Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology.	2004-09-24	15382964
Improving the bacteriological safety of platelet transfusions.	2004-01	14689374
FKF1 is essential for photoperiodic-specific light signalling in Arabidopsis.	2003-11-20	14628054
[Nested case-control study on riboflavin levels in blood and urine and the risk of lung cancer].	2003-11	14963913
Anti-oxidant vitamins and steroid responsive nephrotic syndrome in Indian children.	2002-10	12354259
Abnormal vitamin levels in patients receiving home total parenteral nutrition.	2001-10-19	11606856
Longitudinal vitamin and homocysteine levels in normal pregnancy.	2001-01	11227033
Predictors of micronutrient status among six- to twelve-month-old breast-fed Ghanaian infants.	2000-02	10720170
Elevation of serum riboflavin carrier protein in breast cancer.	1999-11	10566553
Riboflavin levels in maternal milk: the influence of vitamin B2 status during the third trimester of pregnancy.	1999-08	12038475
Folic acid, riboflavin, thiamine, and vitamin B-6 status of a group of first-time blood donors.	1998-11	9808225
Urinary riboflavin excretion after a load test in rural China as a measure of possible riboflavin deficiency.	1990-03	2369885
Bioavailability of riboflavin from fortified palm juice.	1989-12	2631092
Vitamin concentrations in very low birth weight infants given vitamins intravenously in a lipid emulsion: measurement of vitamins A, D, and E and riboflavin.	1988-12	3142982
Urinary riboflavin excretion and erythrocyte glutathione reductase activity in preschool children suffering from upper respiratory infections and measles.	1987	3592624
Analgesic and antidepressive effects of low-dose amitriptyline in relation to its metabolism in patients with chronic pain.	1986-02	3510800
Comparison of riboflavin, vitamin A, and zinc status of Chinese populations at high and low risk for esophageal cancer.	1985	3878498
The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect.	1983-03	6830748
Nutritional status and physical working capacity.	1982	7161138
Riboflavin status in infants born in rural Gambia, and the effect of a weaning food supplement.	1982	7101408

Patents

Sample Use Guides

In Vivo Use Guide

The starting dose of Infuvite Adult is one 10 mL daily dose that is prepared by transferring the content of vial 1 into the content of vial 2 to provide 10 single doses. One 10 mL dose is then added directly to the intravenous fluid. Patients with multiple vitamin deficiencies or with increased vitamin requirements may need multiple daily dosages as indicated. Each 5 mL of Vial 1* contains 3.6 mg of Riboflavin (Vitamin B 2) (as riboflavin 5-phosphate sodium)

Route of Administration: Intravenous

In Vitro Use Guide

Flavin mononucleotide inhibited Cryptosporidium hominis TS-DHFR with IC50 55 uM

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:36:00 GMT 2025` Edited by `admin` on `Mon Mar 31 17:36:00 GMT 2025`
Record UNII	7N464URE7E
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

FLAVIN MONONUCLEOTIDE

Preferred Name

English

RIBOFLAVIN 5'-PHOSPHATE

Common Name

English

VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE)

Common Name

English

RIBOFLAVIN PHOSPHATE [VANDF]

Common Name

English

FMN

Common Name

English

VITAMIN B2 PHOSPHATE

Common Name

English

Riboflavin phosphate [WHO-DD]

Common Name

English

FLAVIN MONONUCLEOTIDE [MI]

Common Name

English

RIBOFLAVIN PHOSPHATE

Common Name

English

RIBOFLAVIN 5'-(DIHYDROGEN PHOSPHATE)

Common Name

English

Classification Tree Code System Code

LOINC

53648-2